2024/05/10 22:30:01 | |
---|---|
Price | |
2.5599 USD | |
Difference | -5.89% (-0.16) |
ISIN | US5393193017 |
Symbol | LIXT |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 5 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 2.40 USD (1,500) |
Ask (Ask size) | 2.79 USD (400) |
Open | 2.75 USD |
High | 2.8212 USD |
Low | 2.48 USD |
Close (prev. day) | 2.72 USD |
VWAP | 2.556423 USD |
Volume (pcs) | 13,533 |
Trading volume | 34,738.06 |
Number of trades | 106 |
Last size | - |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/04/26 | Global Equity Ratings | ||
2024/04/03 | Global Equity Ratings | ||
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings |
2024/05/10 22:30:01 | |
---|---|
Price | |
2.5599 USD | |
Difference | -5.89% (-0.16) |
ISIN | US5393193017 |
Symbol | LIXT |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 5 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 2.40 USD (1,500) |
Ask (Ask size) | 2.79 USD (400) |
Open | 2.75 USD |
High | 2.8212 USD |
Low | 2.48 USD |
Close (prev. day) | 2.72 USD |
VWAP | 2.556423 USD |
Volume (pcs) | 13,533 |
Trading volume | 34,738.06 |
Number of trades | 106 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | -6.91% | -57.90% | -90.52% |
Perf (abs.) | -0.19 | -3.52 | -24.44 |
Beta | 1.27 | 1.10 | 0.86 |
Volatility | 112.08 | 116.89 | 121.49 |
Ø price 5 days | Ø volume 5 days (pcs.) | 2.7590 USD (11,260) |
Ø price 30 days | Ø volume 30 days (pcs.) | 3.1818 USD (53,943) |
Ø price 100 days | Ø volume 100 days (pcs.) | 2.5674 USD (358,941) |
Ø price 250 days | Ø volume 250 days (pcs.) | 3.1778 USD (193,167) |
YTD High | date | 4.4000 USD (2024/03/27) |
YTD Low | date | 1.6900 USD (2024/01/19) |
52 Weeks High | date | 9.5000 USD (2023/07/17) |
52 Weeks Low | date | 1.5800 USD (2023/09/19) |
LIXTE BIOTECHNOLOGY |
- - |
E. Colorado Blvd., Suite 180 680 91101 Pasadena |
Telefon: +1 (631) 830-7092 |
Fax: +1 (631) 982-5050 |
E-mail: info@lixte.com |
- |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer